BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15790932)

  • 1. Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies.
    Sugano R; Matsuoka H; Haramaki N; Umei H; Murase E; Fukami K; Iida S; Ikeda H; Imaizumi T
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1262-7. PubMed ID: 15790932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia.
    Rindone JP; Hiller D; Arriola G
    Pharmacotherapy; 1998; 18(4):836-9. PubMed ID: 9692657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
    Haruna Y; Morita Y; Yada T; Satoh M; Fox DA; Kashihara N
    Arthritis Rheum; 2007 Jun; 56(6):1827-35. PubMed ID: 17530711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercholesterolemia, not metabolic syndrome, related to adhesion of monocytes to cultured endothelium in nondiabetic subjects.
    Lee IT; Lin TM; Lee WJ; Ou HC; Chien YH; Lee WL; Tang YJ; Yang CH; Sheu WH
    Metabolism; 2005 Nov; 54(11):1467-71. PubMed ID: 16253635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels.
    Jakulj L; Vissers MN; Rodenburg J; Wiegman A; Trip MD; Kastelein JJ
    J Pediatr; 2006 Apr; 148(4):495-500. PubMed ID: 16647412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
    Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell superoxide anion radical generation is not dependent on endothelial nitric oxide synthase-serine 1179 phosphorylation and endothelial nitric oxide synthase dimer/monomer distribution.
    Whitsett J; Martásek P; Zhao H; Schauer DW; Hatakeyama K; Kalyanaraman B; Vásquez-Vivar J
    Free Radic Biol Med; 2006 Jun; 40(11):2056-68. PubMed ID: 16716906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
    Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
    Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
    Matsuda N; Hayashi Y; Takahashi Y; Hattori Y
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1348-54. PubMed ID: 17003232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
    Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of high-fat meals enriched with walnuts or olive oil on postprandial endothelial function.
    Cortés B; Núñez I; Cofán M; Gilabert R; Pérez-Heras A; Casals E; Deulofeu R; Ros E
    J Am Coll Cardiol; 2006 Oct; 48(8):1666-71. PubMed ID: 17045905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans.
    Landmesser U; Bahlmann F; Mueller M; Spiekermann S; Kirchhoff N; Schulz S; Manes C; Fischer D; de Groot K; Fliser D; Fauler G; März W; Drexler H
    Circulation; 2005 May; 111(18):2356-63. PubMed ID: 15867181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
    Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
    Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of dyslipidaemias with fluvastatin.
    Peters TK
    Br J Clin Pract Suppl; 1994 Dec; (77):16-9. PubMed ID: 19514133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.
    Reyderman L; Kosoglou T; Cutler DL; Maxwell S; Statkevich P
    Curr Med Res Opin; 2005 Aug; 21(8):1171-9. PubMed ID: 16083526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.